Lastly, our study could uncover site-specific MAP acetylation at particular lysine residues (or combinations thereof) as a critical factor in disease pathogenesis that may distinguish tau from its close relatives, which could factor into the selective tau toxicity observed in AD and related tauopathies. Here, MAPT is linked to tauopathy.